Allstate Corp
XBER:ALS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Allstate Corp
XBER:ALS
|
US |
|
A
|
Abbvie Inc
SIX:ABBV
|
US |
|
M
|
Mitsubishi Corp
XMUN:MBI
|
JP |
|
G
|
General Dynamics Corp
LSE:0IUC
|
US |
|
H
|
Holcim AG
XBER:HLBN
|
CH |
|
C
|
Coca-Cola Femsa SAB de CV
SWB:CFSL
|
MX |
|
W
|
Wynn Resorts Ltd
DUS:WYR
|
US |
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
|
Inventiva SA
NASDAQ:IVA
|
FR |
|
Kweichow Moutai Co Ltd
SSE:600519
|
CN |
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
|
Flex Ltd
NASDAQ:FLEX
|
SG |
|
E
|
EverCommerce Inc
NASDAQ:EVCM
|
US |
|
D
|
Darden Restaurants Inc
DUS:DDN
|
US |
|
Deutsche Bank AG
XETRA:DBK
|
DE |
|
H
|
Humana Inc
SWB:HUM
|
US |
Wall St Price Targets
ALS Price Targets Summary
Allstate Corp
According to Wall Street analysts, the average 1-year price target for ALS is 194.86 EUR with a low forecast of 106.27 EUR and a high forecast of 248.17 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALS's stock price target?
Price Target
194.86
EUR
According to Wall Street analysts, the average 1-year price target for ALS is 194.86 EUR with a low forecast of 106.27 EUR and a high forecast of 248.17 EUR.
What is the Revenue forecast for Allstate Corp?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Allstate Corp?
Projected CAGR
-15%
Over the last 14 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is -15%.
